Is a complete CHRS research report available?

No complete published report is available for Coherus Oncology, Inc. (CHRS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Coherus Oncology, Inc. (CHRS)

NASDAQ: CHRS · USD

$1.16

+0.09 (+8.4%)· Recorded snapshot

Market cap	179.2M
Revenue (ttm)	50.9M
Net income (ttm)	-132.1M
EPS (ttm)	-$1.00
Shares out	154.5M
Volume	1,203,253
Beta	0.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 50.9M
Net income (ttm): -132.1M
EPS (ttm): -$1.00
Market cap: 179.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001512762
Company name	Coherus Oncology, Inc.
Country	United States
Country code	US
CUSIP number	19249H103
Earnings date	2026-11-09
Earnings time	amc
Employees	144
Employees change	-33
Employees growth	-18.64%
Enterprise value	$128.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2014-11-06
Is primary listing	Yes
Is SPAC	No
ISIN number	US19249H1032
Last 10-K release date	2026-03-09
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$179.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.16
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CHRS
U.S. state	California
Website	https://www.coherus.com

Metric

Value

Amount currency

USD

CIK code

0001512762

Company name

Coherus Oncology, Inc.

Country

United States

Country code

CUSIP number

19249H103

Earnings date

2026-11-09

Earnings time

amc

Employees

144

Employees change

-33

Employees growth

-18.64%

Enterprise value

$128.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2014-11-06

Is primary listing

Yes

Is SPAC

ISIN number

US19249H1032

Last 10-K release date

2026-03-09

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$179.2M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.16

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CHRS

U.S. state

California

Website

https://www.coherus.com

Metric	Value
Earnings yield	-86.3%
EV/Sales	2.45x
FCF / EV yield	-148.82%
FCF yield	-105.62%
Forward EV/Sales	1.56x
Forward P/S	2.2x
P/B ratio	2.72x
P/S ratio	3.46x
Price / tangible book value	11.11x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-86.3%

EV/Sales

2.45x

FCF / EV yield

-148.82%

FCF yield

-105.62%

Forward EV/Sales

1.56x

Forward P/S

2.2x

P/B ratio

2.72x

P/S ratio

3.46x

Price / tangible book value

11.11x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBITDA margin	-295.25%
Gross margin	68.96%
Operating margin	-302.33%
Pretax margin	-316.37%
Profit margin	-259.41%
Profit per employee	$-917,583
Profitable years	2
Revenue per employee	$353,722
ROA	-30.52%
ROA (5Y)	-24.85%
ROCE	-133.13%
ROE	-178.39%
ROIC	-324.31%
ROIC (5Y)	-157.67%
SBC / revenue	21.87%

Metric

Value

EBITDA margin

-295.25%

Gross margin

68.96%

Operating margin

-302.33%

Pretax margin

-316.37%

Profit margin

-259.41%

Profit per employee

$-917,583

Profitable years

Revenue per employee

$353,722

ROA

-30.52%

ROA (5Y)

-24.85%

ROCE

-133.13%

ROE

-178.39%

ROIC

-324.31%

ROIC (5Y)

-157.67%

SBC / revenue

21.87%

Metric	Value
EPS growth years	4
Gross profit growth	74.65%
Gross profit growth (Q)	46.81%
Gross profit growth 3Y	-27.13%
Gross profit growth 5Y	-36.85%
Net income growth years	3
Revenue growth	61%
Revenue growth (Q)	39.53%
Revenue growth (QoQ)	16.22%
Revenue growth 10Y	1.52%
Revenue growth 3Y	-34.58%
Revenue growth 5Y	-33.6%
Revenue growth quarters	4
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

74.65%

Gross profit growth (Q)

46.81%

Gross profit growth 3Y

-27.13%

Gross profit growth 5Y

-36.85%

Net income growth years

Revenue growth

61%

Revenue growth (Q)

39.53%

Revenue growth (QoQ)

16.22%

Revenue growth 10Y

1.52%

Revenue growth 3Y

-34.58%

Revenue growth 5Y

-33.6%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$3.6M
EBIT	$-154M
EBITDA	$-150.4M
EPS	$-1.00
FCF per share	$-1.20
Financing cash flow	$61.8M
Free cash flow	$-186M
Free cash flow minus SBC	$-197.2M
Gross profit	$35.1M
Investing cash flow	$-9.8M
Net borrowing	$-121,000
Net cash flow	$-134M
Net income	$-132.1M
Operating cash flow minus SBC	$-197.2M
Operating income	$-154M
Revenue	$50.9M
Stock-based compensation	$11.1M

Metric

Value

Depreciation and amortization

$3.6M

EBIT

$-154M

EBITDA

$-150.4M

EPS

$-1.00

FCF per share

$-1.20

Financing cash flow

$61.8M

Free cash flow

$-186M

Free cash flow minus SBC

$-197.2M

Gross profit

$35.1M

Investing cash flow

$-9.8M

Net borrowing

$-121,000

Net cash flow

$-134M

Net income

$-132.1M

Operating cash flow minus SBC

$-197.2M

Operating income

$-154M

Revenue

$50.9M

Stock-based compensation

$11.1M

Metric	Value
Altman Z-Score	-11.68
Book value per share	$0.39
Debt / equity	0.89
Interest coverage	-16.95
Long-term assets	$57.4M
Long-term liabilities	$54.8M
Net cash (debt)	$51.1M
Net cash / market cap	29.03%
Net cash growth	-72.14%
Net debt / equity	-0.84
Piotroski F-Score	3
Property, plant and equipment	$865,000
Shareholders' equity	$60.8M
Tangible book value	$15.8M
Tangible book value per share	$0.10
Total assets	$191.2M
Total cash	$105.3M
Total debt	$54.2M
Total liabilities	$130.3M
WACC	10.52%

Metric

Value

Altman Z-Score

-11.68

Book value per share

$0.39

Debt / equity

0.89

Interest coverage

-16.95

Long-term assets

$57.4M

Long-term liabilities

$54.8M

Net cash (debt)

$51.1M

Net cash / market cap

29.03%

Net cash growth

-72.14%

Net debt / equity

-0.84

Piotroski F-Score

Property, plant and equipment

$865,000

Shareholders' equity

$60.8M

Tangible book value

$15.8M

Tangible book value per share

$0.10

Total assets

$191.2M

Total cash

$105.3M

Total debt

$54.2M

Total liabilities

$130.3M

WACC

10.52%

Metric	Value
Asset turnover	0.16
Current assets	$133.8M
Current liabilities	$75.5M
Current ratio	1.77
Inventory turnover	3.11
Net working capital	$-45.1M
Quick ratio	1.58
Working capital	$58.3M
Working capital turnover	0.58

Metric

Value

Asset turnover

0.16

Current assets

$133.8M

Current liabilities

$75.5M

Current ratio

1.77

Inventory turnover

3.11

Net working capital

$-45.1M

Quick ratio

1.58

Working capital

$58.3M

Working capital turnover

0.58

Metric	Value
Buyback yield / dilution	-14.13%
Dividend yield	0%
Shareholder yield	-14.13%

Metric

Value

Buyback yield / dilution

-14.13%

Dividend yield

Shareholder yield

-14.13%

Metric	Value
10Y price change	-96.14%
10Y return CAGR	-27.77%
10Y total return	-96.14%
150-day SMA	$1.44
1D price change	8.41%
1M price change	0.89%
1M total return	0.89%
1W price change	14%
1W total return	14%
1Y price change	-28.75%
1Y return CAGR	-28.77%
1Y total return	-28.75%
20-day SMA	$1.05
200-day SMA	$1.54
3M price change	-21.92%
3M total return	-21.92%
3Y price change	-56.82%
3Y return CAGR	-24.41%
3Y total return	-56.82%
50-day SMA	$1.22
50-day SMA vs 200-day SMA	50under200
52-week high	$2.62
52-week high date	2026-01-27
52-week low	$0.94
52-week low date	2026-10-19
5Y price change	-92.91%
5Y return CAGR	-41.1%
5Y total return	-92.91%
6M price change	-38.04%
6M total return	-38.04%
All-time high	$38.10
All-time high date	2015-07-22
All-time low	$0.66
All-time low date	2024-11-05
Average true range (ATR)	$0.07
Average volume	1.3M
Beta (1Y)	1.4
Beta (2Y)	1.28
Beta (5Y)	0.99
Change from 52-week high	-55.66%
Change from 52-week low	23.4%
Change from all-time high	-97.01%
Change from all-time low	72.65%
Change from open	9.43%
Day's gap	-0.93%
Dollar volume	$1.4M
High price	$1.17
Low price	$1.06
Monthly RSI	39.32
Open price	$1.06
Position in 52-week range	95.24%
Premarket change	2.8%
Premarket close	$1.07
Premarket price	$1.10
Premarket volume	56.4K
Previous close	$1.07
Price vs 150-day SMA	-21%
Price vs 20-day SMA	8.16%
Price vs 200-day SMA	-25.88%
Price vs 50-day SMA	-6.25%
Relative volume	0.92
RSI	53.51
Sharpe ratio	-0.08
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	-0.24
Sortino ratio	-0.04
Sortino ratio (3Y)	0.14
Sortino ratio (5Y)	-0.28
Volume	1.2M
Weekly RSI	42
YTD price change	-19.72%
YTD total return	-19.72%

Metric

Value

10Y price change

-96.14%

10Y return CAGR

-27.77%

10Y total return

-96.14%

150-day SMA

$1.44

1D price change

8.41%

1M price change

0.89%

1M total return

0.89%

1W price change

14%

1W total return

14%

1Y price change

-28.75%

1Y return CAGR

-28.77%

1Y total return

-28.75%

20-day SMA

$1.05

200-day SMA

$1.54

3M price change

-21.92%

3M total return

-21.92%

3Y price change

-56.82%

3Y return CAGR

-24.41%

3Y total return

-56.82%

50-day SMA

$1.22

50-day SMA vs 200-day SMA

50under200

52-week high

$2.62

52-week high date

2026-01-27

52-week low

$0.94

52-week low date

2026-10-19

5Y price change

-92.91%

5Y return CAGR

-41.1%

5Y total return

-92.91%

6M price change

-38.04%

6M total return

-38.04%

All-time high

$38.10

All-time high date

2015-07-22

All-time low

$0.66

All-time low date

2024-11-05

Average true range (ATR)

$0.07

Average volume

1.3M

Beta (1Y)

1.4

Beta (2Y)

1.28

Beta (5Y)

0.99

Change from 52-week high

-55.66%

Change from 52-week low

23.4%

Change from all-time high

-97.01%

Change from all-time low

72.65%

Change from open

9.43%

Day's gap

-0.93%

Dollar volume

$1.4M

High price

$1.17

Low price

$1.06

Monthly RSI

39.32

Open price

$1.06

Position in 52-week range

95.24%

Premarket change

2.8%

Premarket close

$1.07

Premarket price

$1.10

Premarket volume

56.4K

Previous close

$1.07

Price vs 150-day SMA

-21%

Price vs 20-day SMA

8.16%

Price vs 200-day SMA

-25.88%

Price vs 50-day SMA

-6.25%

Relative volume

0.92

RSI

53.51

Sharpe ratio

-0.08

Sharpe ratio (3Y)

0.05

Sharpe ratio (5Y)

-0.24

Sortino ratio

-0.04

Sortino ratio (3Y)

0.14

Sortino ratio (5Y)

-0.28

Volume

1.2M

Weekly RSI

YTD price change

-19.72%

YTD total return

-19.72%

Metric	Value
Float	135.6M
Float percentage	87.77%
Shares change (QoQ)	13.5%
Shares change (YoY)	14.13%
Shares held by insiders	12.21%
Shares held by institutions	42.77%
Shares outstanding	154.5M
Short % of float	17.21%
Short % of shares	15.11%
Short ratio	17.7 days

Metric

Value

Float

135.6M

Float percentage

87.77%

Shares change (QoQ)

13.5%

Shares change (YoY)

14.13%

Shares held by insiders

12.21%

Shares held by institutions

42.77%

Shares outstanding

154.5M

Short % of float

17.21%

Short % of shares

15.11%

Short ratio

17.7 days

Coherus Oncology, Inc. (CHRS)

Price

Financial snapshot

Fair-value bridge

Latest news · CHRS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CHRS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CHRS

Frequently asked questions